Byron Miyazawa
-
- Trauma, Hemostasis, Coagulopathy, Resuscitation 13
- Emergency Medicine top 5%
- Trauma and Emergency Care Studies 11
- Biochemistry top 10%
- Blood transfusion and management 5
- Hematology top 10%
- Hemostasis and retained surgical items 2
-
- Sepsis Diagnosis and Treatment 6
-
- Extracellular vesicles in disease 4
-
- Traumatic Brain Injury and Neurovascular Disturbances 3
-
- Diabetic Foot Ulcer Assessment and Management 2
- Co-authors
- Shibani PatiDaniel PotterMichael A. MatthayMatthew K. HowardJean‐François PittetJérémie RouxAlpa TrivediJohn B. Holcomb
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Byron Miyazawa
26 papers receiving 827 citations
Peers
Comparison fields: 5 of 86
- Critical Care and Intensive Care Medicine 219
- Emergency Medicine 156
- Biochemistry 74
- Hematology 87
- Genetics 77
Countries citing papers authored by Byron Miyazawa
This map shows the geographic impact of Byron Miyazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Byron Miyazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Byron Miyazawa more than expected).
Fields of papers citing papers by Byron Miyazawa
This network shows the impact of papers produced by Byron Miyazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Byron Miyazawa. The network helps show where Byron Miyazawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Byron Miyazawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 3 | |
| 4 | 2022 | 2 | |
| 5 | 2021 | 7 | |
| 6 | 2021 | 14 | |
| 7 | 2021 | 23 | |
| 8 | 2020 | 3 | |
| 9 | 2020 | 17 | |
| 10 | 2019 | 64 | |
| 11 | 2019 | 33 | |
| 12 | 2019 | 86 | |
| 13 | 2018 | 51 | |
| 14 | 2017 | 79 | |
| 15 | 2016 | 30 | |
| 16 | 2016 | 19 | |
| 17 | 2015 | 14 | |
| 18 | 2013 | 5 | |
| 19 | 2011 | 32 | |
| 20 | 2010 | 20 |
About Byron Miyazawa
Byron Miyazawa is a scholar working on Critical Care and Intensive Care Medicine, Emergency Medicine and Biochemistry, having authored 27 papers that have together received 834 indexed citations. Recurring topics across this work include Trauma, Hemostasis, Coagulopathy, Resuscitation (13 papers), Trauma and Emergency Care Studies (11 papers), Sepsis Diagnosis and Treatment (6 papers), Blood transfusion and management (5 papers), Extracellular vesicles in disease (4 papers), Traumatic Brain Injury and Neurovascular Disturbances (3 papers), Hemostasis and retained surgical items (2 papers) and Diabetic Foot Ulcer Assessment and Management (2 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (219 citations), Emergency Medicine (156 citations) and Biochemistry (74 citations). Byron Miyazawa has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Shibani Pati, Daniel Potter, Michael A. Matthay, Matthew K. Howard, Jean‐François Pittet, Jérémie Roux, Alpa Trivedi, John B. Holcomb, Amit K. Srivastava and Michael T. Ganter. Their work appears in journals such as PLoS ONE, Circulation Research and Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.